Related Experiment Video
Updated: Aug 14, 2026

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
Published on: August 20, 2016
Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas
S A Collier1, M C Madigan, P L Penfold
1Department of Clinical Ophthalmology, University of Sydney, Sydney, NSW, Australia. scollier@eye.usyd.edu.au
Purpose:
To determine whether MT1-MMP and MMP-2 are expressed in normal and keratoconic corneas, and to investigate the ability of MT1-MMP, expressed on cultured keratocytes after stimulation with concanavalin A, to activate pro-gelatinase A (pro-MMP 2).
Methods:
Specimens of keratoconus corneas (n = 20), removed at corneal transplantation, were obtained from pathology archives, sections were cut, and were stained with an antibody to MT1-MMP, using peroxidase immunohistochemistry. Eye banked corneas served as controls (n = 14). Normal human keratocyte cultures were initiated from eye bank corneas, and after stimulation with con A, MMPs in the media were examined using gelatin zymography and immunoblotting, and MT1-MMP expression was analysed by flow cytometry and immunoblotting.
Results:
All corneas showed some expression of MT1-MMP and MMP-2, although the degree of staining varied greatly. The MMPs were present in the epithelium, endothelium and stroma. Expression of MT1-MMP, but not MMP-2, in the epithelium and stroma, was significantly elevated in keratoconus, compared to normal corneas. In vitro, keratocytes stimulated with con A expressed MT1-MMP and produced active MMP-2, detected by zymography. These responses to con A were concentration-dependent and MT1-MMP expression and MMP-2 activation correlated significantly (p = 0.0003) In addition, MMP inhibitors abolished MMP-2 activation, providing further evidence that MT1-MMP activated MMP-2.
Conclusion:
The observation that MT1-MMP expression may be up-regulated in keratoconus corneas, taken together with the demonstration that human corneal cells can express this enzyme, which in turn can activate latent MMP-2, provide evidence for a possible role for MT1-MMP in the pathogenesis of keratoconus.
Insights
Upregulated MT1-MMP in keratoconus corneas may play a role in disease development. This enzyme, expressed by corneal cells, activates MMP-2, suggesting a potential therapeutic target for keratoconus.
Area of Science:
- Ophthalmology
- Cell Biology
- Biochemistry
Background:
- Keratoconus is a progressive corneal thinning disorder.
- Matrix metalloproteinases (MMPs) are implicated in tissue remodeling and degradation.
- MT1-MMP and MMP-2 are key enzymes in extracellular matrix turnover.
Purpose of the Study:
- To investigate the expression of MT1-MMP and MMP-2 in normal and keratoconic corneas.
- To determine if MT1-MMP on cultured keratocytes can activate pro-MMP-2.
- To explore the role of MT1-MMP in keratoconus pathogenesis.
Main Methods:
- Immunohistochemistry was used to detect MT1-MMP and MMP-2 in corneal tissues.
- Human keratocyte cultures were stimulated with concanavalin A (con A).
- Gelatin zymography, immunoblotting, and flow cytometry analyzed MMP activity and expression.
Main Results:
- Both MT1-MMP and MMP-2 were expressed in all corneas, with higher MT1-MMP levels in keratoconus epithelium and stroma.
- Stimulated keratocytes expressed MT1-MMP and activated pro-MMP-2 in a dose-dependent manner.
- MMP inhibitors blocked MMP-2 activation, confirming MT1-MMP's role.
Conclusions:
- MT1-MMP expression is elevated in keratoconus corneas.
- Human corneal cells express MT1-MMP, which activates latent MMP-2.
- MT1-MMP may contribute to the pathogenesis of keratoconus.
Related Concept Videos
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Matrix Proteoglycans and Glycoproteins
Role of Matrix Metalloproteases in Degradation of ECM
A...

